UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000028794
Receipt number R000032954
Scientific Title salvage therapy by amidotrizoate for sudden deafness showing poor response to steroid therapy
Date of disclosure of the study information 2017/09/01
Last modified on 2019/03/12 19:01:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

salvage therapy by amidotrizoate for sudden deafness showing poor response to steroid therapy

Acronym

salvage therapy by amidotrizoate for sudden deafness showing poor response to steroid therapy

Scientific Title

salvage therapy by amidotrizoate for sudden deafness showing poor response to steroid therapy

Scientific Title:Acronym

salvage therapy by amidotrizoate for sudden deafness showing poor response to steroid therapy

Region

Japan


Condition

Condition

sudden deafness showing poor response to initial treatment with topical or systemic administration of steroid

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

evaluation of safety and clinical efficacy of amidotrizoate therapy as salvage therapy for sudden deafness showing no response to initial treatment with topical or systemic administration of steroid

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

adverse effect during amidotrizoate therapy

Key secondary outcomes

hearing level measured by pure tone audiometry at the end of amidotrizoate therapy


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

NO

Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

twenty milliliter of amidotrizoate is slowly administered intravenously once a day during 7 continuous days

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

sudden deafness showing poor response to initial treatment with topical or systemic administration of steroid

Key exclusion criteria

1. old case
2. thyroid disease
3. allergic disorder including bronchial asthma
4. renal dysfunction
5. past history of cerebellovascular disease and/or brain tumor

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Tetsuya
Middle name
Last name Tono

Organization

University of Miyazaki

Division name

Department of otorhinolaryngology, head and neck surgery

Zip code

8891692

Address

5200, kihara, kiyotake, miyazaki, miyazaki, 8891692, Japan

TEL

+81-985-85-2966

Email

tono@med.miyazaki-u.ac.jp


Public contact

Name of contact person

1st name Takahiro
Middle name
Last name Nakashima

Organization

University of Miyazaki

Division name

Department of otorhinolaryngology, head and neck surgery

Zip code

8891692

Address

5200, kihara, kiyotake, miyazaki, miyazaki, 8891692, Japan

TEL

+85-985-85-2966

Homepage URL


Email

takahiro_nakashima@med.miyazaki-u.ac.jp


Sponsor or person

Institute

University of Miyazaki

Institute

Department

Personal name



Funding Source

Organization

University of Miyazaki

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Clinical research support center

Address

5200, kihara, kiyotake, miyazaki, miyazaki, 8891692, Japan

Tel

+81-985-85-9403

Email

riken@med.miyazaki-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

50

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 04 Month 01 Day

Date of IRB

2015 Year 11 Month 05 Day

Anticipated trial start date

2017 Year 08 Month 28 Day

Last follow-up date

2019 Year 03 Month 22 Day

Date of closure to data entry

2019 Year 03 Month 29 Day

Date trial data considered complete


Date analysis concluded

2019 Year 03 Month 30 Day


Other

Other related information



Management information

Registered date

2017 Year 08 Month 23 Day

Last modified on

2019 Year 03 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032954


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name